Skip to main content
Rapid Micro Biosystems, Inc. (RPID)
NASDAQ: RPID · IEX Real-Time Price · USD
0.695
+0.035 (5.26%)
At close: Jul 19, 2024, 4:00 PM
0.600
-0.095 (-13.63%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Rapid Micro Biosystems Revenue

Rapid Micro Biosystems had revenue of $23.10M in the twelve months ending March 31, 2024, with 28.25% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $5.61M with 11.44% year-over-year growth. In the year 2023, Rapid Micro Biosystems had annual revenue of $22.52M with 31.44% growth.

Revenue (ttm)
$23.10M
Revenue Growth
+28.25%
P/S Ratio
1.29
Revenue / Employee
$119,663
Employees
193
Market Cap
29.78M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202322.52M5.39M31.44%
Dec 31, 202217.13M-6.10M-26.25%
Dec 31, 202123.23M7.16M44.50%
Dec 31, 202016.08M-435.00K-2.63%
Dec 31, 201916.51M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Streamline Health Solutions 21.59M
Spectral AI 19.30M
Evogene 9.19M
bioAffinity Technologies 4.94M
Lipocine 4.71M
Daré Bioscience 2.82M
Pluri 341.00K
Revenue Rankings

RPID News

More News